Sentrian receives $12 million from TELUS Ventures, Reed Elsevier Ventures and Frost Data Capital

Canadian telecom player TELUS has continued its foray into the health space by investing into California-based Sentrian, a remote patient Intelligence company. The total raise was $12 million (USD) and was led by TELUS Ventures, Reed Elsevier Ventures and Frost Data Capital.

Sentrian, originally as ‘Jointly Health’, launched in August 2012 by Dr Jack Kreindler, a physician in healthcare and health tech, and CEO Dean Sawyer. Sentrian desires to eliminate all preventable hospitalization and its “platform leverages the exponential growth in biosensors and machine-learning and is intended to detect the subtle signs that warn of an impending problem before the patient becomes acute and requires hospitalization,” said Sawyer.

Sentrian’s platform is currently being tested by large health insurance plans in controlled studies involving thousands of patients. The company expects to announce the results of those studies in 2015.

“As healthcare moves from volume to value-based reimbursement, tackling preventable hospital admissions becomes an imperative,” said Kevin Brown, General Partner of Reed Elsevier Ventures. “Sentrian has assembled a dream team of entrepreneurs, technologists and physicians and has developed the only analytics platform we’ve seen capable of taking advantage of multivariate remote patient monitoring sensor data at scale. I am thrilled to be joining the Sentrian team as an investor and board member.”